Linda Evangelista CoolSculpting photos were first published by People magazine in February 2022, revealing the physical effects of a cosmetic procedure she says left her “brutally disfigured.” The images showed visible protrusions on her chin, thighs, and bra area that she attributed to a rare complication called paradoxical adipose hyperplasia.
The supermodel had been living in seclusion for nearly five years before sharing those photos with the world. Her decision to speak publicly marked the end of a self-imposed silence that began after what should have been a routine body-contouring treatment went severely wrong.
The Photos and Why She Finally Spoke
The People magazine exclusive featured Evangelista in a brown camisole, showing her body as it appeared after the procedure. She told the publication, “I can’t live like this anymore, in hiding and shame. I just couldn’t live in this pain any longer. I’m willing to finally speak”.
She had previously addressed her condition in a September 2021 Instagram post, stating she was “brutally disfigured” by Zeltiq’s CoolSculpting procedure, which she said “did the opposite of what it promised”. That post announced her intent to sue the company for $50 million in damages.
The model described how the condition affected her professionally. “I loved being up on the catwalk. Now I dread running into someone I know,” she said through tears during the People interview.
What Happened During Her Treatments
Evangelista underwent seven sessions of CoolSculpting between August 2015 and February 2016 at a dermatologist’s office. The treatments targeted her abdomen, flanks, back, bra area, inner thighs, and chin areas she hoped to reduce.
Within three months, she noticed the treated areas were growing rather than shrinking. “I tried to fix it myself, thinking I was doing something wrong,” she told People, describing how she began dieting and exercising excessively. “I got to where I wasn’t eating at all. I thought I was losing my mind”.
Her doctor diagnosed her in June 2016 with Paradoxical adipose hyperplasia, a condition she had never heard of before. The diagnosis meant that no amount of diet or exercise would ever reverse the changes to her body.Quick Bio: Linda Evangelista
Note on Spouse/Partner: Search results did not yield any verified, publicly confirmed spouse or partner for Linda Evangelista. A source claiming she is married to Salma Hayek is clearly erroneous and was excluded .
Note on Net Worth: The $40 million figure is an estimate from entertainment news outlets, not an official financial disclosure .
Understanding Paradoxical Adipose Hyperplasia
PAH is a rare side effect of cryolipolysis, the fat-freezing technology behind CoolSculpting. The FDA acknowledges it as a known risk, characterized by “a visibly enlarged tissue volume within the treatment area” that typically develops two to five months after treatment.
The condition does not resolve on its own and frequently requires surgical intervention. A 2024 review published in ScienceDirect reported incidence rates ranging from 0.0051% to 0.64%. A separate 2025 review in the Aesthetic Surgery Journal Open Forum found a pooled incidence of 0.22%, or roughly 1 in 455 patients.
Dr. Alan Matarasso, a New York plastic surgeon who never treated Evangelista, explained the cruel irony to People: “Patients go in to have something reduced, and now it’s enlarged. And the problem with PAH is that, in some instances, it may not go away”.
The Lawsuit and Its Resolution
Evangelista filed her lawsuit against Zeltiq Aesthetics Inc. in September 2021, alleging negligence and failure to warn customers about PAH risks. The suit claimed she had been unable to work since the treatments and sought $50 million in damages.
She alleged in the suit that the procedure “increased, not decreased” her fat cells, leaving her “permanently deformed even after two painful, unsuccessful, corrective surgeries”. The case was settled in July 2022 for an undisclosed amount, with both sides paying their own legal fees.
In a statement following the settlement, Evangelista said, “I look forward to the next chapter of my life with friends and family, and am happy to put this matter behind me. I am truly grateful for the support I have received from those who have reached out”.
The Regulatory Response and Recall
The FDA maintains a database of adverse event reports for CoolSculpting devices. Multiple MAUDE reports document PAH cases, with one noting that “PAH is not related to any CoolSculpting device failure mode” but is “an inherent risk to the use of cryolipolysis”.
In 2022, Zeltiq initiated a voluntary recall of specific parallel plate applicators after data from 2019 to 2021 showed an increased rate of PAH associated with those devices. The recalled applicators were sold under brand names including CoolCore, CoolCurve, CoolCurve+, CoolMax, and CoolFit.
The company acknowledged that PAH was “observed more frequently with the parallel plate applicators” compared to other device components. This recall represented a significant regulatory acknowledgment that the risk profile of certain applicators had changed over time.
Life After the Diagnosis
Evangelista has spoken candidly about the psychological toll of her experience. In a 2025 interview with Harper’s Bazaar, she revealed, “I have to go through therapy to like what I see when I look in the mirror, and I still don’t look in the mirror”.
She has undergone multiple corrective surgeries, including two liposuction procedures she described as unsuccessful. The model also survived breast cancer twice and underwent a double mastectomy, which she views with a different perspective than the CoolSculpting scars.
“My double mastectomy, I’m fine with it. I did put in very small implants. What they took out, I put in, cc-wise. I’ve had all those lung surgeries, oh my God, and my keloids and all the chest-tube scars and my C-section scar,” she told Harper’s Bazaar. “There were a lot of surgeries. I’m cool. I’m fine with those. I won. I’m here”.
A Changed Perspective on Aging and Beauty
Evangelista has returned to modeling and public life with a transformed outlook. She told Harper’s Bazaar, “I don’t care how I age. I just want to age. It doesn’t have to be gracefully”. The statement reflects a hard-won appreciation for simply being alive after her multiple health battles.
She has dissolved her facial fillers because, as she explained, “I wasn’t looking like me,” though she continues to receive Botox injections. This selective approach to cosmetic procedures suggests a nuanced relationship with beauty enhancement after her traumatic experience.
Her message about self-acceptance remains a work in progress. “I’m doing the work, and I’m trying to get to the place where I like myself, flaws and all, and trying to love myself,” she told Harper’s Bazaar. “I’m alive, and I’m going to do what I have to do. I’m going to fight because I don’t want it any other way. I’m not done”.
The Linda Evangelista CoolSculpting photos document a chapter she has now largely put behind her legally, but the physical and emotional scars remain part of her story. Her willingness to share that story has contributed to broader awareness about the potential risks of cosmetic procedures marketed as non-invasive and risk-free.
What is Paradoxical Adipose Hyperplasia (PAH)? PAH is a rare complication of cryolipolysis, the fat-freezing technology used in CoolSculpting. Instead of shrinking, the treated fat tissue thickens and expands, creating hardened bulges that typically appear two to five months after the procedure. The condition does not resolve on its own and often requires surgical correction through liposuction or abdominoplasty.
How many CoolSculpting sessions did Linda Evangelista undergo, and where? Evangelista had seven sessions between August 2015 and February 2016. The treatments targeted her abdomen, flanks, back, bra area, inner thighs, and chin. Within three months, she noticed the treated areas were hardening and growing rather than reducing.
What was the outcome of her lawsuit against CoolSculpting? Evangelista sued Zeltiq Aesthetics Inc. for $50 million in 2021, alleging negligence and failure to warn about PAH risks. The case was settled in July 2022 for an undisclosed amount. She stated afterward that she looked forward to “the next chapter” of her life.
Did the manufacturer take any action after her case? Yes. In 2022, Zeltiq voluntarily recalled several first-generation CoolSculpting parallel plate applicators, including CoolCore, CoolCurve, CoolCurve+, CoolMax, and CoolFit. The recall followed data from 2019 to 2021 showing an increased PAH rate of approximately 1 in 1,000 treatments with those specific applicators.
How common is PAH, and does it resolve? Reported incidence rates vary widely, from 0.0051% to 0.64% in published studies, with a 2025 review finding a pooled rate of roughly 0.22% (1 in 455 patients). The condition is permanent without surgery. A 2023 review of 33 patients found all cases required power-assisted liposuction, with most achieving improvement or complete resolution after surgical intervention.
